Daniel Riester
Papers
1
Total Citations
3
H-Index
1
About
Daniel Riester is a pioneer in the integration of miniaturized robotic systems for preclinical drug discovery, with a core focus on merging chemical synthesis and biological screening into seamless, automated workflows. His landmark work, "Robotic alliance of miniaturized synthesis and screening: A case study for the identification of histone deacetylase inhibitors" (2013), demonstrated a transformative approach that eliminates the need for traditional compound storage—a major bottleneck in pharmaceutical development. By coupling high-throughput synthesis directly with screening, Riester’s methodology accelerates the identification of bioactive molecules, such as histone deacetylase inhibitors, which are critical targets in cancer and epigenetic research. Though his most cited paper has garnered modest attention, its conceptual impact is significant, offering a blueprint for reducing compound degradation and logistical complexity in early-stage drug development. Riester’s contributions are especially valuable for researchers seeking to streamline the drug discovery pipeline, and his work continues to inspire innovations in lab automation and miniaturized reaction technologies.
Research Focus
Key Achievements
Top Papers
- 1